These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis? Kanis JA Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799 [No Abstract] [Full Text] [Related]
3. Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause? Stevenson JC Osteoporos Int; 1998; 8 Suppl 1():S47-50. PubMed ID: 9682798 [No Abstract] [Full Text] [Related]
4. [Estrogen replacement therapy in osteoporosis]. Hirvonen E Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218 [No Abstract] [Full Text] [Related]
5. Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density. De Leo V; Morgante G; la Marca A; Lanzetta D; Cobellis L; Petraglia F Gynecol Endocrinol; 2003 Aug; 17(4):329-32. PubMed ID: 14503978 [TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of bone mineral density during estrogen replacement therapy. Thijssen JH; Druckmann R Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():29-34. PubMed ID: 10862266 [No Abstract] [Full Text] [Related]
8. Clinical value of bone densitometry. Sartoris DJ AJR Am J Roentgenol; 1994 Jul; 163(1):133-5. PubMed ID: 8010199 [TBL] [Abstract][Full Text] [Related]
10. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?]. MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093 [No Abstract] [Full Text] [Related]
12. [Bone density screening in females in climacteric]. Heytmanek G Wien Med Wochenschr; 1992; 142(5-6):130-2. PubMed ID: 1615683 [TBL] [Abstract][Full Text] [Related]
13. Osteoporosis screening: time to take responsibility. Mazanec D Arch Intern Med; 2004 May; 164(10):1047-8. PubMed ID: 15159261 [No Abstract] [Full Text] [Related]
14. [What is reliable in the treatment of osteoporosis in menopausal women?]. Ziegler R Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570 [No Abstract] [Full Text] [Related]
15. Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis? Schwartz K; Chang SI J Fam Pract; 2001 Dec; 50(12):1024-5. PubMed ID: 11742601 [No Abstract] [Full Text] [Related]
16. Bone preservation and the menopause. Fraser WD Br J Hosp Med; 1997 Mar 5-18; 57(5):212-4. PubMed ID: 9176601 [No Abstract] [Full Text] [Related]
17. The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up. Prelevic GM; Markou A; Arnold A; Bartram C; Puzigaca Z; Ginsburg J Maturitas; 2004 Mar; 47(3):229-34. PubMed ID: 15036493 [TBL] [Abstract][Full Text] [Related]
18. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT. Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299 [TBL] [Abstract][Full Text] [Related]
19. Beyond bone mineral density: several factors define bone health. Ruhl C Nurs Womens Health; 2008 Jun; 12(3):249-51. PubMed ID: 18557856 [No Abstract] [Full Text] [Related]